What Happened?
Baltimore, MD-based WindMIL-Therapeutics Appointed Brian Halak as Chief Executive Officer
About the Company
WindMIL Therapeutics is a clinical stage oncology cell therapy company. We are leveraging our proprietary platform to develop a novel class of cell therapies called MILs™ (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow.
About the Person
Brian Halak is Chief Executive Officer at WindMIL Therapeutics. Previously, Brian held various senior HR leadership roles in the industry.
Info Source
News
Short Profile